Symbols / PGNY Stock $25.88 +1.57% Progyny, Inc.

Healthcare • Healthcare Plans • United States • NMS
PGNY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Healthcare Plans
CEO Mr. Peter Anevski CPA
Exch · Country NMS · United States
Market Cap 2.03B
Enterprise Value 1.80B
Income 67.69M
Sales 1.29B
FCF (ttm) 200.21M
Book/sh 6.24
Cash/sh 2.87
Employees 835
Insider 10d —
IPO Oct 25, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 33.61
Forward P/E 11.73
PEG —
P/S 1.57
P/B 4.15
P/C —
EV/EBITDA 16.42
EV/Sales 1.39
Quick Ratio 2.07
Current Ratio 2.13
Debt/Eq 6.21
LT Debt/Eq —
EPS (ttm) 0.77
EPS next Y 2.21
EPS Growth 70.60%
Revenue Growth 1.40%
EPS Gr Q/Q 60.90%
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-07
ROA 9.12%
ROE 14.94%
ROIC —
Gross Margin 24.11%
Oper. Margin 10.77%
Profit Margin 5.24%
Shs Outstand 78.33M
Shs Float 71.70M
Insider Own 1.95%
Instit Own 111.93%
Short Float 9.70%
Short Ratio 3.38
Short Interest 5.42M
52W High 28.75
vs 52W High -9.98%
52W Low 16.10
vs 52W Low 60.75%
Beta 1.04
Impl. Vol. 58.35%
Rel Volume 0.20
Avg Volume 1.54M
Volume 300.92K
Target (mean) $29.73
Tgt Median $30.00
Tgt Low $26.00
Tgt High $31.00
# Analysts 11
Recom Strong_buy
Prev Close $25.48
Price $25.88
Change 1.57%
About

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$29.73
Mean price target
2. Current target
$25.88
Latest analyst target
3. DCF / Fair value
$46.01
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$25.88
Low
$26.00
High
$31.00
Mean
$29.73

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-06-02 main B of A Securities Buy → Buy $31
2026-05-19 up Canaccord Genuity Hold → Buy $30
2026-05-18 main Barclays Overweight → Overweight $27
2026-05-11 main Truist Securities Buy → Buy $30
2026-05-11 main Citizens Market Outperform → Market Outperform $31
2026-03-20 main Barclays Overweight → Overweight $23
2026-03-11 main Canaccord Genuity Hold → Hold $19
2026-03-05 main BTIG Buy → Buy $30
2026-03-02 main Keybanc Overweight → Overweight $28
2026-03-02 main Truist Securities Buy → Buy $28
2026-01-20 up Citizens Market Perform → Market Outperform $30
2026-01-08 main Keybanc Overweight → Overweight $32
2025-12-09 init Barclays — → Overweight $29
2025-11-17 main Canaccord Genuity Hold → Hold $26
2025-11-12 up Keybanc Sector Weight → Overweight $30
2025-11-11 main JP Morgan Neutral → Neutral $26
2025-08-26 main JP Morgan Neutral → Neutral $25
2025-08-20 main Canaccord Genuity Hold → Hold $23
2025-08-08 main Cantor Fitzgerald Overweight → Overweight $28
2025-07-17 main Truist Securities Hold → Hold $27
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-02 CLAPP GEOFFREY Officer — 12,909 $20.91 $269,927
2026-06-02 LIVINGSTON MARK S Chief Financial Officer — 279 $26.20 $7,310
2026-06-02 CLAPP GEOFFREY Officer — 1,530 $25.58 $39,137
2026-06-01 SCOTT CHERYL M Director — 14,667 $13.00 $190,671
2026-06-01 SCOTT CHERYL M Director — 7,439 $26.38 $196,278
2026-05-28 SWARTZ ALLISON General Counsel — 2,398 $25.46 $61,053
2026-05-27 GORDON KEVIN K Director — 5,500 $24.99 $137,445
2026-05-21 GORDON KEVIN K Director — 6,792 $0.00 $0
2026-05-21 PAYSON NORMAN Director — 5,660 $0.00 $0
2026-05-21 HOLSTEIN ROGER C Director — 6,792 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,288.66
+10.40%
1,167.22
+7.22%
1,088.60
+38.34%
786.91
Operating Revenue
1,288.66
+10.40%
1,167.22
+7.22%
1,088.60
+38.34%
786.91
Cost Of Revenue
984.18
+7.69%
913.86
+7.54%
849.80
+37.16%
619.59
Reconciled Cost Of Revenue
984.18
+7.69%
913.86
+7.54%
849.80
+37.16%
619.59
Gross Profit
304.48
+20.18%
253.36
+6.10%
238.80
+42.72%
167.32
Operating Expense
219.21
+17.91%
185.91
+5.26%
176.62
+22.66%
143.98
Selling General And Administration
219.21
+17.91%
185.91
+5.26%
176.62
+22.66%
143.98
Selling And Marketing Expense
72.11
+12.77%
63.95
+7.50%
59.49
+30.29%
45.66
General And Administrative Expense
147.09
+20.61%
121.96
+4.13%
117.13
+19.12%
98.33
Other Gand A
147.09
+20.61%
121.96
+4.13%
117.13
+19.12%
98.33
Total Expenses
1,203.38
+9.42%
1,099.77
+7.15%
1,026.41
+34.42%
763.57
Operating Income
85.28
+26.42%
67.45
+8.48%
62.18
+166.42%
23.34
Total Operating Income As Reported
85.28
+26.42%
67.45
+8.48%
62.18
+166.42%
23.34
EBITDA
90.22
+27.74%
70.63
+9.56%
64.47
+158.46%
24.94
Normalized EBITDA
90.22
+27.74%
70.63
+9.56%
64.47
+158.46%
24.94
Reconciled Depreciation
4.95
+55.84%
3.17
+39.19%
2.28
+42.47%
1.60
EBIT
85.28
+26.42%
67.45
+8.48%
62.18
+166.42%
23.34
Net Income
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Pretax Income
95.43
+14.70%
83.20
+17.70%
70.69
+189.23%
24.44
Net Non Operating Interest Income Expense
10.15
-35.51%
15.75
+85.11%
8.51
+673.36%
1.10
Net Interest Income
10.15
-35.51%
15.75
+85.11%
8.51
+673.36%
1.10
Interest Income Non Operating
10.15
-35.51%
15.75
+85.11%
8.51
+673.36%
1.10
Interest Income
10.15
-35.51%
15.75
+85.11%
8.51
+673.36%
1.10
Other Income Expense
—
—
5.20
+1719.23%
0.29
Other Non Operating Income Expenses
—
—
5.20
+1719.23%
0.29
Tax Provision
36.91
+27.87%
28.87
+233.56%
8.65
+246.26%
-5.92
Tax Rate For Calcs
0.00
+11.55%
0.00
+183.40%
0.00
-41.70%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Net Income From Continuing Operation Net Minority Interest
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Net Income From Continuing And Discontinued Operation
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Net Income Continuous Operations
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Normalized Income
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Net Income Common Stockholders
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Diluted EPS
0.65
+14.04%
0.57
-8.06%
0.62
+106.67%
0.30
Basic EPS
0.68
+15.25%
0.59
-9.23%
0.65
+96.97%
0.33
Basic Average Shares
85.65
-6.37%
91.48
-3.72%
95.02
+3.07%
92.20
Diluted Average Shares
89.86
-5.85%
95.45
-5.19%
100.67
+0.72%
99.96
Diluted NI Availto Com Stockholders
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Total Other Finance Cost
—
—
-3.30
-305.90%
-0.81
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
742.43
+22.29%
607.10
-19.76%
756.62
+39.34%
542.99
Current Assets
551.77
+16.72%
472.72
-26.18%
640.41
+47.61%
433.86
Cash Cash Equivalents And Short Term Investments
310.10
+36.03%
227.95
-38.57%
371.09
+96.03%
189.30
Cash And Cash Equivalents
112.24
-30.85%
162.31
+66.82%
97.30
-18.97%
120.08
Other Short Term Investments
197.86
+201.43%
65.64
-76.03%
273.79
+295.53%
69.22
Receivables
220.29
-6.39%
235.32
-2.71%
241.87
+0.75%
240.07
Accounts Receivable
220.29
-6.39%
235.32
-2.71%
241.87
+0.75%
240.07
Gross Accounts Receivable
275.95
-5.39%
291.68
+1.10%
288.50
+7.49%
268.39
Allowance For Doubtful Accounts Receivable
-55.66
+1.24%
-56.35
-20.84%
-46.64
-64.63%
-28.33
Prepaid Assets
—
—
—
—
Other Current Assets
21.39
+126.54%
9.44
-65.60%
27.45
+511.52%
4.49
Total Non Current Assets
190.66
+41.88%
134.38
+15.63%
116.21
+6.49%
109.13
Net PPE
54.92
+85.32%
29.63
+6.53%
27.82
+82.13%
15.27
Gross PPE
67.26
+76.99%
38.00
+14.74%
33.12
+80.06%
18.39
Accumulated Depreciation
-12.34
-47.51%
-8.37
-57.86%
-5.30
-69.96%
-3.12
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
37.42
+128.82%
16.35
+38.82%
11.78
+45.52%
8.10
Other Properties
24.99
+44.86%
17.25
-2.01%
17.61
+155.03%
6.90
Leases
4.85
+10.30%
4.40
+17.79%
3.73
+9.99%
3.39
Goodwill And Other Intangible Assets
26.19
+55.57%
16.84
+41.73%
11.88
-0.83%
11.98
Goodwill
19.98
+28.61%
15.53
+30.76%
11.88
+0.00%
11.88
Other Intangible Assets
6.22
+377.05%
1.30
—
0.10
Non Current Deferred Assets
93.01
+9.51%
84.93
+16.16%
73.12
-6.12%
77.89
Non Current Deferred Taxes Assets
93.01
+9.51%
84.93
+16.16%
73.12
-6.12%
77.89
Other Non Current Assets
16.54
+455.46%
2.98
-12.31%
3.40
-14.87%
3.99
Total Liabilities Net Minority Interest
226.39
+22.35%
185.04
-8.93%
203.19
+22.39%
166.02
Current Liabilities
202.39
+20.02%
168.63
-9.32%
185.95
+16.56%
159.54
Payables And Accrued Expenses
175.19
+20.08%
145.90
-14.56%
170.75
+14.27%
149.43
Payables
154.03
+21.07%
127.22
-18.30%
155.72
+10.89%
140.43
Accounts Payable
124.07
+30.47%
95.10
-24.18%
125.43
+14.77%
109.29
Other Payable
29.95
-6.75%
32.12
+6.03%
30.29
-2.71%
31.14
Current Accrued Expenses
21.16
+13.29%
18.68
+24.28%
15.03
+66.93%
9.00
Pensionand Other Post Retirement Benefit Plans Current
21.57
+47.99%
14.57
+22.78%
11.87
+54.01%
7.71
Current Debt And Capital Lease Obligation
3.73
+30.33%
2.86
+33.04%
2.15
+74.57%
1.23
Current Capital Lease Obligation
3.73
+30.33%
2.86
+33.04%
2.15
+74.57%
1.23
Other Current Liabilities
1.91
-63.88%
5.30
+347.93%
1.18
+1.20%
1.17
Total Non Current Liabilities Net Minority Interest
24.00
+46.23%
16.41
-4.80%
17.24
+165.98%
6.48
Long Term Debt And Capital Lease Obligation
24.00
+46.23%
16.41
-4.80%
17.24
+165.98%
6.48
Long Term Capital Lease Obligation
24.00
+46.23%
16.41
-4.80%
17.24
+165.98%
6.48
Stockholders Equity
516.04
+22.27%
422.06
-23.74%
553.43
+46.81%
376.97
Common Stock Equity
516.04
+22.27%
422.06
-23.74%
553.43
+46.81%
376.97
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Share Issued
99.67
+1.38%
98.31
+1.39%
96.96
+3.24%
93.92
Ordinary Shares Number
83.37
-2.28%
85.31
-11.46%
96.35
+3.27%
93.30
Treasury Shares Number
16.30
+25.40%
13.00
+2010.16%
0.62
+0.00%
0.62
Additional Paid In Capital
700.78
+20.49%
581.60
+25.99%
461.64
+32.07%
349.53
Retained Earnings
202.83
+40.55%
144.31
+60.39%
89.97
+222.08%
27.93
Gains Losses Not Affecting Retained Earnings
0.50
+1176.92%
0.04
-98.62%
2.82
+462.67%
0.50
Treasury Stock
388.07
+27.70%
303.89
+30017.84%
1.01
+0.00%
1.01
Other Equity Adjustments
0.50
+1176.92%
0.04
-98.62%
2.82
+462.67%
0.50
Total Equity Gross Minority Interest
516.04
+22.27%
422.06
-23.74%
553.43
+46.81%
376.97
Total Capitalization
516.04
+22.27%
422.06
-23.74%
553.43
+46.81%
376.97
Working Capital
349.38
+14.89%
304.09
-33.09%
454.46
+65.67%
274.32
Invested Capital
516.04
+22.27%
422.06
-23.74%
553.43
+46.81%
376.97
Total Debt
27.73
+43.87%
19.27
-0.61%
19.39
+151.39%
7.71
Capital Lease Obligations
27.73
+43.87%
19.27
-0.61%
19.39
+151.39%
7.71
Net Tangible Assets
489.85
+20.88%
405.23
-25.17%
541.55
+48.37%
364.99
Tangible Book Value
489.85
+20.88%
405.23
-25.17%
541.55
+48.37%
364.99
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
210.19
+17.36%
179.10
-5.14%
188.81
+134.86%
80.39
Cash Flow From Continuing Operating Activities
210.19
+17.36%
179.10
-5.14%
188.81
+134.86%
80.39
Net Income From Continuing Operations
58.52
+7.70%
54.34
-12.41%
62.04
+104.35%
30.36
Depreciation Amortization Depletion
4.95
+55.84%
3.17
+39.19%
2.28
+42.47%
1.60
Depreciation And Amortization
4.95
+55.84%
3.17
+39.19%
2.28
+42.47%
1.60
Other Non Cash Items
0.43
—
-0.03
—
Stock Based Compensation
131.87
+2.92%
128.13
+4.50%
122.61
+21.70%
100.75
Asset Impairment Charge
20.53
+25.19%
16.40
-17.75%
19.93
+44.51%
13.79
Deferred Tax
-8.12
+22.39%
-10.46
-379.20%
3.75
+156.61%
-6.62
Deferred Income Tax
-8.12
+22.39%
-10.46
-379.20%
3.75
+156.61%
-6.62
Operating Gains Losses
0.08
-94.41%
1.41
+17775.00%
-0.01
—
Gain Loss On Investment Securities
—
-2.12
+51.13%
-4.33
—
Net Foreign Currency Exchange Gain Loss
0.00
0.00
+100.00%
-0.01
0.00
Gain Loss On Sale Of PPE
0.08
-94.41%
1.41
0.00
0.00
Change In Working Capital
2.80
+123.77%
-11.78
+32.42%
-17.42
+70.71%
-59.49
Change In Receivables
-5.12
+48.18%
-9.87
+54.58%
-21.74
+81.78%
-119.30
Changes In Account Receivables
-5.12
+48.18%
-9.87
+54.58%
-21.74
+81.78%
-119.30
Change In Prepaid Assets
-11.95
-166.31%
18.02
+178.58%
-22.93
-40328.07%
0.06
Change In Payables And Accrued Expense
29.17
+243.38%
-20.34
-176.49%
26.60
-56.28%
60.84
Change In Accrued Expense
0.42
-95.80%
9.92
-4.22%
10.36
-21.19%
13.15
Change In Payable
28.75
+194.99%
-30.27
-286.44%
16.23
-65.96%
47.69
Change In Account Payable
28.75
+194.99%
-30.27
-286.44%
16.23
-65.96%
47.69
Change In Other Working Capital
-9.31
-2289.65%
0.42
-34.41%
0.65
+160.00%
-1.08
Investing Cash Flow
-159.01
-181.22%
195.79
+197.64%
-200.53
-357.13%
-43.87
Cash Flow From Continuing Investing Activities
-159.01
-181.22%
195.79
+197.64%
-200.53
-357.13%
-43.87
Cash From Discontinued Investing Activities
—
—
—
—
Net PPE Purchase And Sale
-18.41
-240.61%
-5.41
-48.33%
-3.64
-12.43%
-3.24
Purchase Of PPE
-18.41
-240.61%
-5.41
-48.33%
-3.64
-12.43%
-3.24
Capital Expenditure
-18.41
-240.61%
-5.41
-48.33%
-3.64
-12.43%
-3.24
Net Investment Purchase And Sale
-131.26
-163.57%
206.50
+204.89%
-196.88
-384.63%
-40.62
Purchase Of Investment
-354.96
-108.39%
-170.34
+60.36%
-429.69
-163.08%
-163.33
Sale Of Investment
223.70
-40.64%
376.84
+61.86%
232.81
+89.73%
122.71
Net Business Purchase And Sale
-9.34
-76.09%
-5.30
0.00
0.00
Purchase Of Business
-9.34
-76.09%
-5.30
0.00
0.00
Financing Cash Flow
-99.36
+67.94%
-309.88
-2698.77%
-11.07
-40.79%
-7.86
Cash Flow From Continuing Financing Activities
-99.36
+67.94%
-309.88
-2698.77%
-11.07
-40.79%
-7.86
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
—
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
-81.66
+72.81%
-300.28
0.00
0.00
Common Stock Payments
-81.66
+72.81%
-300.28
0.00
0.00
Repurchase Of Capital Stock
-81.66
+72.81%
-300.28
0.00
0.00
Proceeds From Stock Option Exercised
1.23
-48.73%
2.40
-60.85%
6.13
+45.04%
4.22
Net Other Financing Charges
-18.93
-57.78%
-12.00
+30.23%
-17.20
-42.28%
-12.09
Changes In Cash
-48.18
-174.11%
65.02
+385.38%
-22.78
-179.48%
28.66
Effect Of Exchange Rate Changes
0.06
+6100.00%
0.00
+0.00%
0.00
0.00
Beginning Cash Position
162.31
+66.82%
97.30
-18.97%
120.08
+31.36%
91.41
End Cash Position
114.19
-29.65%
162.31
+66.82%
97.30
-18.97%
120.08
Free Cash Flow
191.78
+10.41%
173.70
-6.19%
185.17
+140.00%
77.15
Interest Paid Supplemental Data
—
—
—
—
Income Tax Paid Supplemental Data
55.49
+37.19%
40.45
+554.41%
6.18
+4547.37%
0.13
Amortization Of Securities
-0.87
+59.05%
-2.12
+51.13%
-4.33
—
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category